Research ArticleArticle
Characteristics and Outcomes of Patients with Systemic Lupus Erythematosus–associated Thrombotic Microangiopathy, and Their Acquired ADAMTS13 Inhibitor Profiles
Cai Yue, Jian Su, Ruitong Gao, Yubing Wen, Chao Li, Gang Chen, Xuan Zhang and Xuemei Li
The Journal of Rheumatology July 2018, jrheum.170811; DOI: https://doi.org/10.3899/jrheum.170811
Cai Yue
From the Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing; Thrombosis and Hemostasis Research Unit, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University, Suzhou; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China. Supported by the Chinese Academy of Medical Sciences (Grant No. 2017-I2M-2-001). C. Yue, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; J. Su, MD, Thrombosis and Hemostasis Research Unit, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University; R. Gao, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; Y. Wen, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; C. Li, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; G. Chen, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; X. Zhang, MD, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; X. Li, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College. Address correspondence to Dr. X. Li, 1 Shuai Fu Yuan, Beijing, China, 100730. E-mail: lixmpumch@126.com; or Dr. X. Zhang, 1 Shuai Fu Yuan, Beijing, China, 100730. E-mail: zxpumch2003@sina.com. Accepted for publication May 10, 2018.
Jian Su
From the Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing; Thrombosis and Hemostasis Research Unit, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University, Suzhou; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China. Supported by the Chinese Academy of Medical Sciences (Grant No. 2017-I2M-2-001). C. Yue, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; J. Su, MD, Thrombosis and Hemostasis Research Unit, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University; R. Gao, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; Y. Wen, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; C. Li, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; G. Chen, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; X. Zhang, MD, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; X. Li, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College. Address correspondence to Dr. X. Li, 1 Shuai Fu Yuan, Beijing, China, 100730. E-mail: lixmpumch@126.com; or Dr. X. Zhang, 1 Shuai Fu Yuan, Beijing, China, 100730. E-mail: zxpumch2003@sina.com. Accepted for publication May 10, 2018.
Ruitong Gao
From the Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing; Thrombosis and Hemostasis Research Unit, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University, Suzhou; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China. Supported by the Chinese Academy of Medical Sciences (Grant No. 2017-I2M-2-001). C. Yue, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; J. Su, MD, Thrombosis and Hemostasis Research Unit, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University; R. Gao, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; Y. Wen, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; C. Li, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; G. Chen, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; X. Zhang, MD, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; X. Li, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College. Address correspondence to Dr. X. Li, 1 Shuai Fu Yuan, Beijing, China, 100730. E-mail: lixmpumch@126.com; or Dr. X. Zhang, 1 Shuai Fu Yuan, Beijing, China, 100730. E-mail: zxpumch2003@sina.com. Accepted for publication May 10, 2018.
Yubing Wen
From the Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing; Thrombosis and Hemostasis Research Unit, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University, Suzhou; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China. Supported by the Chinese Academy of Medical Sciences (Grant No. 2017-I2M-2-001). C. Yue, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; J. Su, MD, Thrombosis and Hemostasis Research Unit, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University; R. Gao, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; Y. Wen, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; C. Li, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; G. Chen, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; X. Zhang, MD, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; X. Li, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College. Address correspondence to Dr. X. Li, 1 Shuai Fu Yuan, Beijing, China, 100730. E-mail: lixmpumch@126.com; or Dr. X. Zhang, 1 Shuai Fu Yuan, Beijing, China, 100730. E-mail: zxpumch2003@sina.com. Accepted for publication May 10, 2018.
Chao Li
From the Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing; Thrombosis and Hemostasis Research Unit, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University, Suzhou; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China. Supported by the Chinese Academy of Medical Sciences (Grant No. 2017-I2M-2-001). C. Yue, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; J. Su, MD, Thrombosis and Hemostasis Research Unit, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University; R. Gao, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; Y. Wen, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; C. Li, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; G. Chen, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; X. Zhang, MD, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; X. Li, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College. Address correspondence to Dr. X. Li, 1 Shuai Fu Yuan, Beijing, China, 100730. E-mail: lixmpumch@126.com; or Dr. X. Zhang, 1 Shuai Fu Yuan, Beijing, China, 100730. E-mail: zxpumch2003@sina.com. Accepted for publication May 10, 2018.
Gang Chen
From the Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing; Thrombosis and Hemostasis Research Unit, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University, Suzhou; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China. Supported by the Chinese Academy of Medical Sciences (Grant No. 2017-I2M-2-001). C. Yue, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; J. Su, MD, Thrombosis and Hemostasis Research Unit, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University; R. Gao, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; Y. Wen, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; C. Li, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; G. Chen, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; X. Zhang, MD, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; X. Li, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College. Address correspondence to Dr. X. Li, 1 Shuai Fu Yuan, Beijing, China, 100730. E-mail: lixmpumch@126.com; or Dr. X. Zhang, 1 Shuai Fu Yuan, Beijing, China, 100730. E-mail: zxpumch2003@sina.com. Accepted for publication May 10, 2018.
Xuan Zhang
From the Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing; Thrombosis and Hemostasis Research Unit, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University, Suzhou; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China. Supported by the Chinese Academy of Medical Sciences (Grant No. 2017-I2M-2-001). C. Yue, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; J. Su, MD, Thrombosis and Hemostasis Research Unit, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University; R. Gao, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; Y. Wen, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; C. Li, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; G. Chen, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; X. Zhang, MD, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; X. Li, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College. Address correspondence to Dr. X. Li, 1 Shuai Fu Yuan, Beijing, China, 100730. E-mail: lixmpumch@126.com; or Dr. X. Zhang, 1 Shuai Fu Yuan, Beijing, China, 100730. E-mail: zxpumch2003@sina.com. Accepted for publication May 10, 2018.
Xuemei Li
From the Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing; Thrombosis and Hemostasis Research Unit, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University, Suzhou; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China. Supported by the Chinese Academy of Medical Sciences (Grant No. 2017-I2M-2-001). C. Yue, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; J. Su, MD, Thrombosis and Hemostasis Research Unit, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University; R. Gao, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; Y. Wen, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; C. Li, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; G. Chen, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; X. Zhang, MD, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; X. Li, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College. Address correspondence to Dr. X. Li, 1 Shuai Fu Yuan, Beijing, China, 100730. E-mail: lixmpumch@126.com; or Dr. X. Zhang, 1 Shuai Fu Yuan, Beijing, China, 100730. E-mail: zxpumch2003@sina.com. Accepted for publication May 10, 2018.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Characteristics and Outcomes of Patients with Systemic Lupus Erythematosus–associated Thrombotic Microangiopathy, and Their Acquired ADAMTS13 Inhibitor Profiles
Cai Yue, Jian Su, Ruitong Gao, Yubing Wen, Chao Li, Gang Chen, Xuan Zhang, Xuemei Li
The Journal of Rheumatology Jul 2018, jrheum.170811; DOI: 10.3899/jrheum.170811
Characteristics and Outcomes of Patients with Systemic Lupus Erythematosus–associated Thrombotic Microangiopathy, and Their Acquired ADAMTS13 Inhibitor Profiles
Cai Yue, Jian Su, Ruitong Gao, Yubing Wen, Chao Li, Gang Chen, Xuan Zhang, Xuemei Li
The Journal of Rheumatology Jul 2018, jrheum.170811; DOI: 10.3899/jrheum.170811